A team of scientists at the University of California, San Francisco and Compugen, Ltd. has discovered a new molecule of the immune system -- a member of a family of proteins called chemokines which recruit the body's army of defensive immune cells to sites of invasion.
October 05, 2000
October 04, 2000
The UCSF Comprehensive Cancer Center is enrolling patients for three clinical trials to investigate a new treatment for kidney cancer, prostate cancer and melanoma. The trials aim is to determine if early immune cells, called stem cells, can be collected and transferred from a patient’s sibling into the patient to attack the cancer.
October 03, 2000
The University of California, San Francisco Audiology Clinic will launch new research in October to study the world’s first disposable hearing aids, costing about $40 and lasting approximately 40 days.
October 01, 2000
University of California San Francisco researchers may have discovered why the experimental anti-cancer drug Onyx-015 works more broadly than had been expected...
September 28, 2000
Cardiopulmonary (CPR) training can relieve stress for parents and improve survival outcomes for infants at high risk for cardiopulmonary arrest, a new study has found.
September 25, 2000
A team led by a University of California, San Francisco scientist has developed drug-like inhibitors to study vital signaling molecules essential for almost all cell activity.
September 20, 2000
Jeffrey A. Bluestone, PhD, one of the world's leading experts on why the body's immune system rejects or tolerates transplanted tissue, has been appointed to a new professorship at the University of California, San Francisco devoted to diabetes research.
September 18, 2000
A new $50 million dollar research program launched this month will begin the daunting task of mapping out the thousands of molecular interactions that cells use in responding to their environment.
September 07, 2000
In an effort to strengthen women’s health research in a variety of disciplines, the National Institutes of Health has awarded a grant to the University of California, San Francisco and to the Kaiser Permanente Division of Research in Oakland to create a scholarship program to train young investigators in women’s health and bolster research in this area.
September 07, 2000
The new optimism expressed by healthcare providers treating HIV seropositive patients is mitigated by concerns surrounding treatment decisions and skepticism about the future according to a new University of California, San Francisco study.